SCHEMBL7873802

SCHEMBL7873802

CCN(CC)Cc1ccccc1COc1ccc2cc(C(=O)N(C)C(=N)N)[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
RXFP1 Q9HBX9 2/20 0.46
FLT3 P36888 3/20 0.41
PDGFRB P09619 5/20 0.38
PDGFRA P16234 5/20 0.38
ACHE P22303 1/20 0.37
MAOB P27338 1/20 0.37
PLG P00747 1/20 0.37
PLAU P00749 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
SRD5A2 P31213 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CFD P00746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
PARP15 Q460N3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7882019 0.92 MEN1 (0.48) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7884905 0.89 MEN1 (0.47) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7873705 0.88 MEN1 (0.46) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7882345 0.86 MEN1 (0.48) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7885051 0.85 MEN1 (0.34) MEN1KMT2ARXFP1FLT3ACHE
SCHEMBL7881845 0.83 MAOB (0.36) MEN1KMT2ARXFP1ACHEMAOB
SCHEMBL7879925 0.82 FLT3 (0.50) MEN1KMT2ARXFP1FLT3PDGFRB
Hydrochloric Acid SCHEMBL7877487 0.82 FLT3 (0.58) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7873235 0.82 FLT3 (0.47) MEN1KMT2ARXFP1FLT3PDGFRB
SCHEMBL7884458 0.81 MAPT (0.39) MEN1KMT2AFLT3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed